Atrás
Rango del Día
$183.02
$185.00
Rango de 52 Semanas
$110.04
$202.41
Volumen
895,806
Promedio 50D / 200D
$184.31
/
$156.87
Cierre Anterior
$181.46
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 20.8 | 0.4 |
| P/B | 1.5 | 2.9 |
| ROE % | 7.4 | 3.7 |
| Net Margin % | 13.2 | 3.8 |
| Rev Growth 5Y % | -2.8 | 10.0 |
| D/E | 0.4 | 0.2 |
Puntos Clave
Revenue declined -2.78% annually over 5 years
Earnings declined -20.76% over the past year
Debt/Equity of 0.38 — conservative balance sheet
Generating 2.05B in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 4.17%
Cash machine — converts 158.56% of earnings into free cash flow
Crecimiento
Revenue Growth (5Y)
-2.78%
Revenue (1Y)1.39%
Earnings (1Y)-20.76%
FCF Growth (3Y)28.82%
Calidad
Return on Equity
7.40%
ROIC5.59%
Net Margin13.18%
Op. Margin19.14%
Seguridad
Debt / Equity
0.38
Current Ratio2.68
Interest Coverage7.63
Valoración
P/E Ratio
20.84
P/B Ratio1.48
EV/EBITDA16.45
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1.39% | Revenue Growth (3Y) | -0.13% |
| Earnings Growth (1Y) | -20.76% | Earnings Growth (3Y) | 5.54% |
| Revenue Growth (5Y) | -2.78% | Earnings Growth (5Y) | -4.52% |
| Profitability | |||
| Revenue (TTM) | 9.81B | Net Income (TTM) | 1.29B |
| ROE | 7.40% | ROA | 4.39% |
| Gross Margin | 70.47% | Operating Margin | 19.14% |
| Net Margin | 13.18% | Free Cash Flow (TTM) | 2.05B |
| ROIC | 5.59% | FCF Growth (3Y) | 28.82% |
| Safety | |||
| Debt / Equity | 0.38 | Current Ratio | 2.68 |
| Interest Coverage | 7.63 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 20.84 | P/B Ratio | 1.48 |
| P/S Ratio | 2.75 | PEG Ratio | -0.95 |
| EV/EBITDA | 16.45 | Dividend Yield | 0.00% |
| Market Cap | 26.95B | Enterprise Value | 30.89B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 9.81B | 9.68B | 9.84B | 10.17B | 10.98B |
| Net Income | 1.29B | 1.63B | 1.16B | 3.05B | 1.56B |
| EPS (Diluted) | 8.83 | 11.19 | 7.97 | 20.87 | 10.40 |
| Gross Profit | 6.91B | 7.37B | 7.30B | 7.90B | 8.87B |
| Operating Income | 1.88B | 2.49B | 2.10B | 2.89B | 2.79B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 29.44B | 28.05B | 26.84B | 24.55B | 23.88B |
| Total Liabilities | 11.18B | 11.33B | 12.05B | 11.17B | 12.92B |
| Shareholders' Equity | 18.26B | 16.72B | 14.80B | 13.40B | 10.90B |
| Total Debt | 6.95B | 6.63B | 7.34B | 6.61B | 7.60B |
| Cash & Equivalents | 3.01B | 2.38B | 1.05B | 3.42B | 2.26B |
| Current Assets | 8.97B | 7.46B | 6.86B | 9.79B | 7.86B |
| Current Liabilities | 3.35B | 5.53B | 3.43B | 3.27B | 4.30B |